Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0055 |
Primary information | |
---|---|
B3PDB ID | b3pdb_0055 |
Peptide Name | Tfr2 |
PEPTIDE SEQUENCE (1-letter) | HAIYPRH |
PEPTIDE SEQUENCE (3-letter) | HisAlaIleTyrProArgHis |
N-terminal modification | FAM is conjgated at the N-terminal |
C-terminal modification | NA |
Chemical modification | NA |
Peptide Length | 7 |
Conformation | Linear |
Peptide Nature | NA |
Source/Origin of peptide | Chemically synthesized |
SMILES | N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)O |
Cell Line | bEnd.3 cells |
In vitro CONCENTRATION | NA |
In vitro METHOD | Immunofluorescence microscopy |
In vitro RESULT | It shows the permeability towards the BBB. |
ANIMAL MODEL | NA |
In vivo CONCENTRATION | NA |
In vivo MODE OF DELIVERY | NA |
In vivo METHOD | NA |
In vivo RESULT | NA |
ACTION | These novel peptide conjugates have the capacity to act as promising brain shuttles |
TRANSPORT TYPE | Receptor-mediated transcytosis |
SUBCELLULAR LOCALISATION | NA |
COMBINATION | Combined |
PHYSICAL CONDITION | NA |
RESPONSE | NA |
RESULT | NA |
LABEL | NA |
PMID | 32055384 |